8,325 Shares in Sanofi (NASDAQ:SNY) Acquired by Ashton Thomas Private Wealth LLC

Ashton Thomas Private Wealth LLC purchased a new position in shares of Sanofi (NASDAQ:SNY) in the 4th quarter, Holdings Channel.com reports. The firm purchased 8,325 shares of the company’s stock, valued at approximately $402,000.

Several other large investors have also recently made changes to their positions in SNY. Synergy Asset Management LLC purchased a new stake in shares of Sanofi during the fourth quarter worth approximately $25,000. McClarren Financial Advisors Inc. increased its position in shares of Sanofi by 952.6% during the fourth quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company’s stock worth $28,000 after purchasing an additional 543 shares in the last quarter. Sunbelt Securities Inc. increased its position in shares of Sanofi by 72.1% during the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock worth $43,000 after purchasing an additional 313 shares in the last quarter. Sierra Ocean LLC purchased a new stake in shares of Sanofi during the fourth quarter worth approximately $44,000. Finally, Versant Capital Management Inc purchased a new stake in shares of Sanofi during the fourth quarter worth approximately $54,000. 14.04% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft raised Sanofi from a “sell” rating to a “hold” rating in a research note on Thursday, January 30th. StockNews.com lowered Sanofi from a “buy” rating to a “hold” rating in a research note on Thursday, December 12th. Finally, Sanford C. Bernstein raised Sanofi to a “strong-buy” rating in a research note on Thursday, January 30th. Two analysts have rated the stock with a hold rating, one has issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $60.00.

Sanofi Stock Performance

NASDAQ SNY opened at $59.35 on Tuesday. Sanofi has a fifty-two week low of $45.22 and a fifty-two week high of $60.21. The stock’s fifty day moving average is $52.87 and its two-hundred day moving average is $52.76. The firm has a market capitalization of $150.62 billion, a P/E ratio of 23.84, a price-to-earnings-growth ratio of 1.01 and a beta of 0.58. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.14 and a current ratio of 1.46.

Sanofi (NASDAQ:SNY) last announced its quarterly earnings results on Thursday, January 30th. The company reported $0.70 EPS for the quarter, meeting the consensus estimate of $0.70. Sanofi had a return on equity of 25.61% and a net margin of 12.77%. On average, research analysts anticipate that Sanofi will post 4.36 earnings per share for the current year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.